SZSE:002004 (China)
Â
Class A
Â¥
4.39
-0.020 (-0.45%)
Sep 17
Business Description
Huapont Life Science Co Ltd
SIC : 2879
ISIN : CNE000001JJ6
Share Class Description:
SZSE:002004: Class ATotal Employee Number:
11,950Compare
Compare
Traded in other countries / regions
002004.China Index Membership
CSI 500 IndexSZSE Component Index IPO Date
2004-06-25Description
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.58 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.76 | |||||
Debt-to-EBITDA | 5.64 | |||||
Interest Coverage | 6.04 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.18 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.4 | |||||
3-Year EBITDA Growth Rate | -5.2 | |||||
3-Year EPS without NRI Growth Rate | 16.5 | |||||
3-Year FCF Growth Rate | 4.6 | |||||
3-Year Book Growth Rate | 0.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.6 | |||||
9-Day RSI | 42.58 | |||||
14-Day RSI | 45.33 | |||||
3-1 Month Momentum % | 7.38 | |||||
6-1 Month Momentum % | -17.1 | |||||
12-1 Month Momentum % | -3.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.51 | |||||
Days Inventory | 104.33 | |||||
Days Sales Outstanding | 73.7 | |||||
Days Payable | 98.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 10.2 | |||||
Dividend Payout Ratio | 1.04 | |||||
3-Year Dividend Growth Rate | -3.1 | |||||
Forward Dividend Yield % | 10.2 | |||||
5-Year Yield-on-Cost % | 9.65 | |||||
Shareholder Yield % | 25.22 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.72 | |||||
Operating Margin % | 14.16 | |||||
Net Margin % | 5.61 | |||||
EBITDA Margin % | 11.79 | |||||
FCF Margin % | 15.26 | |||||
OCF Margin % | 20.59 | |||||
ROE % | 6.42 | |||||
ROA % | 2.19 | |||||
ROIC % | 5.67 | |||||
3-Year ROIIC % | 6.06 | |||||
ROC (Joel Greenblatt) % | 11.57 | |||||
ROCE % | 6.6 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.43 | |||||
PE Ratio without NRI | 13.47 | |||||
Shiller PE Ratio | 18.29 | |||||
PS Ratio | 0.76 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 1.33 | |||||
Price-to-Free-Cash-Flow | 5.38 | |||||
Price-to-Operating-Cash-Flow | 3.87 | |||||
EV-to-EBIT | 14.2 | |||||
EV-to-EBITDA | 7.45 | |||||
EV-to-Revenue | 1.64 | |||||
EV-to-FCF | 10.73 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Projected-FCF | 0.53 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Graham-Number | 0.77 | |||||
Earnings Yield (Greenblatt) % | 7.04 | |||||
FCF Yield % | 20.15 | |||||
Forward Rate of Return (Yacktman) % | -14.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Huapont Life Science Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 11,477.208 | ||
| EPS (TTM) (Â¥) | 0.327 | ||
| Beta | 0.8886 | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.17 | ||
| Volatility % | 28.18 | ||
| 14-Day RSI | 45.33 | ||
| 14-Day ATR (Â¥) | 0.136459 | ||
| 20-Day SMA (Â¥) | 4.4875 | ||
| 12-1 Month Momentum % | -3.84 | ||
| 52-Week Range (Â¥) | 3.88 - 6.08 | ||
| Shares Outstanding (Mil) | 1,979.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Huapont Life Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Huapont Life Science Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.250000 Cash Dividend | 2026-06-16 | 4.66 (+0.87%) | ||
| CNY 0.200000 Cash Dividend | 2025-09-16 | 4.90 (-0.81%) | ||
| 2.5:1 Stock Split | 2015-05-27 | 19.50 (+6.19%) | ||
| 1.5:1 Stock Split | 2012-09-04 | 6.58 (+1.98%) | ||
| 2:1 Stock Split | 2012-05-15 | 5.64 (-0.98%) | ||
| 1.33:1 Stock Split | 2005-11-03 | 0.91 (+0.00%) | ||
| 1.5:1 Stock Split | 2004-10-18 | 0.97 (+1.61%) |
Show
Entries
Huapont Life Science Co Ltd Frequently Asked Questions
What is Huapont Life Science Co Ltd(SZSE:002004)'s stock price today?
The current price of SZSE:002004 is ¥4.39. The 52 week high of SZSE:002004 is ¥6.08 and 52 week low is ¥3.88.
When is next earnings date of Huapont Life Science Co Ltd(SZSE:002004)?
The next earnings date of Huapont Life Science Co Ltd(SZSE:002004) is .
Does Huapont Life Science Co Ltd(SZSE:002004) pay dividends? If so, how much?
The Dividend Yield %  of Huapont Life Science Co Ltd(SZSE:002004) is 10.2% (As of Today), Highest Dividend Payout Ratio of Huapont Life Science Co Ltd(SZSE:002004) was 1.79. The lowest was 0.61. And the median was 0.79. The  Forward Dividend Yield % of Huapont Life Science Co Ltd(SZSE:002004) is 10.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers